Treating patients who have chronic pain conditions has long held challenges and been rife
with pitfalls for health care professionals. Pain is a complex and dynamic phenomenon …

The comorbidity of pain and depression has been well established in the literature and is
associated with a greater burden to the individual and society than either condition alone. The …

Chronic pain has long been considered an important risk factor for suicidal behavior. Less
well understood are the factors associated with the increased risk for suicide death within …

… AL Hassett has received research funding from Bristol-Myers (Princeton, NJ) and is a
consultant for Lexicon Pharmaceuticals (The Woodlands, TX). The other authors have no conflicts …

Fibromyalgia (FM) is a non-inflammatory rheumatologic disorder characterized by
musculoskeletal pain, fatigue, depression, cognitive dysfunction and sleep disturbance. Research …

Pain is the predominant symptom for people with inflammatory arthritis (IA) and osteoarthritis
(OA) mandating the development of evidence-based recommendations for the health …

Objective Although 2 recent studies have found associations between catastrophizing and
poor medical outcomes in patients with fibromyalgia syndrome (FMS), neither assessed these …

… Hassett has received research funding from Bristol-Myers Squibb and Jazz Pharmaceuticals
and is a consultant to Jazz Pharmaceuticals and Bristol-Myers Squibb. Dr. Fitzcharles has …

… Hassett has received consulting fees from Lexicon Pharmaceuticals (less than $10,000) and
research funding from Bristol-Myers Squibb. Dr. Williams has received consulting fees from …

We determined rates and predictors of future development of fibromyalgia in patients with
rheumatoid arthritis (RA). After excluding patients with fibromyalgia and those with high levels …